Wen S - Search Results

1

Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer.

Yu J, Gao W, Gao S, Wen S, Zhao Y, Shang Z, Wang Y, Niu Y. Yu J, et al. Among authors: wen s. World J Urol. 2022 Nov;40(11):2817-2824. doi: 10.1007/s00345-022-04170-5. Epub 2022 Oct 7. World J Urol. 2022. PMID: 36205741

2

Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells.

Wen S, Shang Z, Zhu S, Chang C, Niu Y. Wen S, et al. Prostate. 2013 Sep;73(12):1306-15. doi: 10.1002/pros.22676. Epub 2013 Jun 15. Prostate. 2013. PMID: 23775364

3

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.

Wen S, Niu Y, Lee SO, Chang C. Wen S, et al. Cancer Treat Rev. 2014 Feb;40(1):31-40. doi: 10.1016/j.ctrv.2013.07.008. Epub 2013 Aug 7. Cancer Treat Rev. 2014. PMID: 23993415 Free PMC article. Review.

4

Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.

Wen S, Chang HC, Tian J, Shang Z, Niu Y, Chang C. Wen S, et al. Am J Pathol. 2015 Feb;185(2):293-301. doi: 10.1016/j.ajpath.2014.10.012. Epub 2014 Nov 26. Am J Pathol. 2015. PMID: 25432062 Free PMC article. Review.

5

What is the next generation therapeutic strategy for castration-resistant prostate cancer.

Wen SM, Quan CY, Jiang N, Shang ZQ, Niu YJ. Wen SM, et al. Asian J Androl. 2015 Mar-Apr;17(2):223-4. doi: 10.4103/1008-682X.143311. Asian J Androl. 2015. PMID: 25432503 Free PMC article.

6

BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts.

Wen S, Niu Y, Yeh S, Chang C. Wen S, et al. Int J Oncol. 2015 Aug;47(2):719-27. doi: 10.3892/ijo.2015.3060. Epub 2015 Jun 22. Int J Oncol. 2015. PMID: 26095189 Free PMC article.

7

Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.

Wen S, Niu Y, Lee SO, Yeh S, Shang Z, Gao H, Li Y, Chou F, Chang C. Wen S, et al. Mol Carcinog. 2016 Dec;55(12):2278-2290. doi: 10.1002/mc.22468. Epub 2016 Feb 19. Mol Carcinog. 2016. PMID: 26894509

8

ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals.

Wen S, Tian J, Niu Y, Li L, Yeh S, Chang C. Wen S, et al. Cancer Lett. 2016 Jul 1;376(2):377-86. doi: 10.1016/j.canlet.2016.01.057. Epub 2016 Apr 1. Cancer Lett. 2016. PMID: 27045473

9

Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer.

Shang Z, Li Y, Hsu I, Zhang M, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. Shang Z, et al. Among authors: wen s. Oncotarget. 2016 May 10;7(19):27325-35. doi: 10.18632/oncotarget.8756. Oncotarget. 2016. PMID: 27092883 Free PMC article.

10

ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis.

Niu Y, Guo C, Wen S, Tian J, Luo J, Wang K, Tian H, Yeh S, Chang C. Niu Y, et al. Among authors: wen s. Cancer Lett. 2018 Dec 28;439:47-55. doi: 10.1016/j.canlet.2018.09.020. Epub 2018 Sep 15. Cancer Lett. 2018. PMID: 30227222 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,858 results

Search Page

Filters